Announce Date | 05/07/2025 |
EPS Normalized Actual | $0.14 (Beat by $0.04) |
EPS GAAP Actual | $0.14 (Beat by $0.04) |
Revenue Actual | $0.342786B |
Revenue Surprise | Beat by $342.786M |
Announce Date | 06/30/2025 (Pre-Market) |
EPS Normalized Estimate | $0.17417 |
EPS GAAP Estimate | $0.17417 |
Revenue Estimate | $0.381756128B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2029 | 1.7 | 37.31 | 1.66829 | 1.74286 | 1 |
Dec 2028 | 0.96 | 66.07 | 0.93719 | 0.98943 | 1 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ4 2024 (Dec 2024) | 0.0315 | 0.0315 | 0.342786B | 25.87% | 342.79M |
FQ3 2024 (Sep 2024) | 0.11 | 0.11 | 0.338212B | 21.79% | 338.21M |
FQ2 2024 (Jun 2024) | 0.12 | 0.12 | 0.324918B | 23.09% | 324.92M |
FQ1 2020 (Mar 2020) | 0 | 0 | 0.0754295B | 100% | 75.43M |
FQ2 2020 (Jun 2020) | 0 | 0 | 0.0754295B | 100% | 75.43M |
FQ1 2024 (Mar 2024) | 0.08 | 0.08 | 0.275099B | 28.29% | 275.1M |
FQ4 2023 (Dec 2023) | -0.0186 | -0.0186 | 0.254123B | 100% | 254.12M |
FQ3 2023 (Sep 2023) | 0.07 | 0.07 | 0.264507B | 100% | 264.51M |
FQ4 Announce Date
06/30/2025 (Pre-Market)
Consensus EPS Estimates
0.17417
Consensus Revenue Estimates
0.381756128B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2027 (Sep 2027) | 0.29302 | -- | 0.28252 | 0.30095 | 3 |
FQ2 2027 (Jun 2027) | 0.34798 | -- | 0.33551 | 0.3574 | 5 |
FQ1 2027 (Mar 2027) | 0.24406 | -- | 0.23531 | 0.25066 | 3 |
FQ4 2026 (Oct 2026) | 0.19855 | -- | 0.19529 | 0.20334 | 1 |
FQ3 2026 (Jul 2026) | 0.19777 | -- | 0.19452 | 0.20254 | 1 |
FQ2 2026 (Jun 2026) | 0.25649 | -- | 0.24998 | 0.26192 | 4 |
FQ1 2026 (Mar 2026) | 0.11658 | -- | 0.11473 | 0.11782 | 3 |
FQ4 2025 (Oct 2025) | 0.15574 | 79.77 | 0.15318 | 0.1595 | 2 |
FQ3 2025 (Jul 2025) | 0.16257 | 32.34 | 0.1599 | 0.16649 | 2 |
FQ2 2025 (Jun 2025) | 0.17417 | 31.1 | 0.16975 | 0.17786 | 3 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2027 (Sep 2027) | 0.6B | -- | 0.58B | 0.61B | 4 |
FQ2 2027 (Jun 2027) | 0.59B | -- | 0.58B | 0.6B | 6 |
FQ1 2027 (Mar 2027) | 0.51B | -- | 0.49B | 0.52B | 4 |
FQ4 2026 (Oct 2026) | 0.47B | -- | 0.46B | 0.48B | 4 |
FQ3 2026 (Jul 2026) | 0.46B | -- | 0.46B | 0.47B | 4 |
FQ2 2026 (Jun 2026) | 0.48B | -- | 0.47B | 0.49B | 6 |
FQ1 2026 (Mar 2026) | 0.39B | -- | 0.38B | 0.39B | 4 |
FQ4 2025 (Oct 2025) | 0.4B | 13.49 | 0.39B | 0.4B | 2 |
FQ3 2025 (Jul 2025) | 0.39B | 12.22 | 0.38B | 0.39B | 2 |
FQ2 2025 (Jun 2025) | 0.38B | 14.89 | 0.37B | 0.39B | 5 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
5
EPS # of Misses
1
EPS # of in-lines
2
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ4 2024 (Dec 2024) | 0.0315 | 0.0315 | 100% | |
FQ3 2024 (Sep 2024) | 0.11 | 0.11 | 100% | |
FQ2 2024 (Jun 2024) | 0.12 | 0.12 | 100% | |
FQ1 2020 (Mar 2020) | 0 | 0 | NAN% | |
FQ2 2020 (Jun 2020) | 0 | 0 | NAN% | |
FQ1 2024 (Mar 2024) | 0.08 | 0.08 | 100% | |
FQ4 2023 (Dec 2023) | -0.0186 | -0.0186 | 100% | |
FQ3 2023 (Sep 2023) | 0.07 | 0.07 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ4 2024 (Dec 2024) | $0B | $0.34B | $342.79M | 100% |
FQ3 2024 (Sep 2024) | $0B | $0.34B | $338.21M | 100% |
FQ2 2024 (Jun 2024) | $0B | $0.32B | $324.92M | 100% |
FQ1 2020 (Mar 2020) | $0B | $0.08B | $75.43M | 100% |
FQ2 2020 (Jun 2020) | $0B | $0.08B | $75.43M | 100% |
FQ1 2024 (Mar 2024) | $0B | $0.28B | $275.1M | 100% |
FQ4 2023 (Dec 2023) | $0B | $0.25B | $254.12M | 100% |
FQ3 2023 (Sep 2023) | $0B | $0.26B | $264.51M | 100% |